Cardiol Therapeutics Inc. (CRDL.TO) TSX

1.36

+0.01(+0.74%)

Updated at January 14 03:40PM

Currency In CAD

Valuation

Market Cap132.4M
Enterprise Value101.98M
P/E Ratio-3.29
PEG Ratio-0.26
Price/Sales Ratio0
Price/Book Ratio11.96
Enterprise/Revenue0
Enterprise/EBITDA-2.96

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-2.69
Return On Equity-2.18

Income Statement

Revenue0
Revenue/Share0
Gross Profit-373,114
EBITDA-36.3M
Net Income-36.68M
Diluted EPS-0.51

Balance Sheet

Total Cash11.62M
Total Cash/Share0.14
Total Debt134,199
Total Debt/Equity0.01
Current Ratio3.89
Book Value Per Share0.11

Price History

52-Week Change-24.58
52-Week High2.17
52-Week Low1.09
Moving Average 50 Days1.42
Moving Average 200 Days1.57

Statistics

Average Volume111,524
Shares Outstanding87.39M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A